Vaxart, Inc.
General ticker "VXRT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $110.6M (TTM average)
Vaxart, Inc. does not follow the US Stock Market performance with the rate: -7.1%.
Estimated limits based on current volatility of 3.4%: low 0.35$, high 0.37$
Factors to consider:
- Total employees count: 109 (-33.5%) as of 2023
- Top business risk factors: Significant losses, Vaccine dependency, No viable vaccine, Need for additional capital, Pandemic risks
- Current price 18.6% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.45$, 1.23$]
- 2025-12-31 to 2026-12-31 estimated range: [0.38$, 1.08$]
Financial Metrics affecting the VXRT estimates:
- Positive: with PPE of -1.9 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -14.60 <= 0.33
- Positive: 18.93 < Shareholder equity ratio, % of 35.41 <= 41.86
- Negative: negative Industry operating cash flow (median)
- Positive: -14.38 < Investing cash flow per share per price, % of -6.96
- Positive: Inventory ratio change, % of -69.50 <= -0.75
Short-term VXRT quotes
Long-term VXRT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.11MM | $7.38MM | $28.70MM |
| Operating Expenses | $114.69MM | $90.73MM | $94.99MM |
| Operating Income | $-114.59MM | $-83.35MM | $-66.29MM |
| Non-Operating Income | $6.90MM | $1.14MM | $-0.40MM |
| Interest Expense | $1.30MM | $1.45MM | $2.97MM |
| R&D Expense | $81.05MM | $68.14MM | $74.21MM |
| Income(Loss) | $-107.69MM | $-82.20MM | $-66.69MM |
| Taxes | $0.07MM | $0.26MM | $0.26MM |
| Profit(Loss)* | $-107.76MM | $-82.47MM | $-66.95MM |
| Stockholders Equity | $110.60MM | $57.80MM | $58.92MM |
| Inventory | $2.00MM | $0.00MM | $0.00MM |
| Assets | $153.85MM | $91.83MM | $166.39MM |
| Operating Cash Flow | $-94.78MM | $-70.45MM | $-44.76MM |
| Capital expenditure | $9.60MM | $1.87MM | $0.55MM |
| Investing Cash Flow | $-20.41MM | $43.95MM | $-21.32MM |
| Financing Cash Flow | $17.46MM | $15.24MM | $56.56MM |
| Earnings Per Share** | $-0.22 | $-0.17 | $-0.14 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.